European Lithium Nears Merger Completion with a War Chest and a Greenland Rare Earth Prize
European Lithium is barrelling toward the finish line of its all-share takeover by Critical Metals Corp, with a…
Novo Nordisk at a Tipping Point: Oral Wegovy Nears EU Market as US Formulary Edge Disappears
EMA recommends oral Wegovy approval as CVS Caremark removes Novo Nordisk’s exclusivity, adding Lilly’s drugs; stock plunges 44%…
Novo Nordisk’s Oral Wegovy Nears EU Approval as Weight-Loss Pill Shifts Competitive Dynamics
CHMP recommends 25-mg semaglutide tablet for weight management and CV risk; first oral GLP-1 in EU. Novo plans…
Novo Nordisk Presses Forward With Oral Semaglutide and Amycretin as CagriSema Nears FDA Verdict
Novo Nordisk awaits FDA decisions on CagriSema and oral Ozempic, expands paediatric GLP-1 approvals, and advances Amycretin for…
Novo Nordisk’s Distribution Push Collides With Margin Squeeze as Pipeline Nears Inflection
Oral Wegovy scripts soar, but US pricing pressure and India generics erode margins. Stock down 35% in a…
Novo Nordisk’s Dividend Yield Nears 5% as Washington Shuffle and Medicare Price Caps Reshape the G
Novo Nordisk’s stock slide pushes dividend yield toward 5%, but pricing pressure and a Washington lobbying pivot signal…
European Lithium’s Share Buyback Signals Confidence as Greenland Project Nears Milestone
European Lithium shares jump 9% as subsidiary Critical Metals gains 10%. Key drivers: Tanbreez rare earths project advances,…